May Taymaa, Oza Amit M
Division of Gynecologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
Clin Cancer Res. 2020 Sep 1;26(17):4432-4434. doi: 10.1158/1078-0432.CCR-20-1376. Epub 2020 Jun 29.
The modeled Ca125 ELIMination rate constant K (KELIM) can be used as a measure of chemotherapy sensitivity in women with newly diagnosed advanced epithelial ovarian cancer who are being treated with neoadjuvant chemotherapy. This marker may aid in decision-making regarding surgical resection and alternate systemic treatments in this cohort..
建模的Ca125清除率常数K（KELIM）可作为新诊断的晚期上皮性卵巢癌女性患者接受新辅助化疗时化疗敏感性的一种衡量指标。该标志物可能有助于该队列患者在手术切除和替代全身治疗方面的决策。
